Pantoprazol: En ny syrepumpehœmmer til brug mod ulcussygdom og refluksøsofagit

Ugeskrift for Laeger

Volumn 158, Issue 12, 1996, Pages 1695-1697

  Wilson, Benedicte V L ^a   Knudsen, Torben ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PANTOPRAZOLE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTIULCER AGENT; BENZIMIDAZOLE DERIVATIVE; DRUG DERIVATIVE; OMEPRAZOLE; SULFOXIDE;

DIGESTIVE SYSTEM ULCER; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG STRUCTURE; DRUG TOLERANCE; HUMAN; PHARMACODYNAMICS; REFLUX ESOPHAGITIS; SHORT SURVEY; SIDE EFFECT; ARTICLE; CHEMISTRY; PEPTIC ULCER;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-ULCER AGENTS; BENZIMIDAZOLES; ESOPHAGITIS, PEPTIC; HUMANS; OMEPRAZOLE; PEPTIC ULCER; SULFOXIDES;

EID: 0030591924     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Shin JM, Besancon M, Simon A, Sachs G. The site of action of pantoprazole in the gastric HYKT-ATPase. Biochim Biophys Acta 1993; 1148: 223-33.
2. Simon B, Müller P, Marinis E, Lühmann R, Huber R, Hartmann M et al. Effect of repeated oral administration of BY 1023/SK&F 96022 - a new substituted benzimidazoie derivative - on pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man. Aliment Pharmacol Ther 1990; 4: 373-9.
3. Müssig S, Witzel L. Steady-state intragastric pH-profile after 40 mg pantoprazole: comparison of morning and evening administration [abstract]. Gastroenterology 1993; 104 (suppl 4); A154.
4. Londong W. Effect of pantoprazole on 24-h intragastric pH and serum gastrin in humans. Aliment Pharmacol Ther 1994; 8 (suppl 1): 39-46.
5. Reill L, Erhardt F, Fischer R, Londong W. Intragastric pH and serum gastrin after one week treatment with pantoprazole, ranitidine or placebo in man [abstract]. Gastroenterology 1993; 104 (suppl 4):A177.
6. Hartmann M, Theiss U, Bliesath H, Wieckhorst G, Lühmann R, Huber R et al. Comparison of the 24h intragastric pH profiles following single and repeated oral intake of pantoprazole 40 mg and omeprazole 20 mg in healthy male volunteers [abstract]. Gastroenterology 1993; 104 (suppl 4): A95.
7. Pue MA, Laroche J, Meineke I, de Mey C. Pharmacokinetics of pantoprazole following single intravenous and oral administration to healthy male subjects. Eur J Clin Pharmacol 1993; 44: 575-8.
8. -ATPase inhibitor BY 1023/SK&F 96022-inhibition of pentaga-strin-stimulated gastric acid secretion and pharmacokinetics in man. Aliment Pharmacol Ther 1990; 4: 239-45.
9. +ATPase inhibitor pantoprazole after single intravenous administration. Int J Clin Pharmacol Ther 1994; 32: 44-50.
10. +-ATPase-inhibitor pantoprazole (BY 1023/SK&F 96022) in healthy volunteers. Z Gastroenterol 1990; 28: 443-7.
11. Benet LZ. Zech K. Pharmacokinetics - a relevant factor for the choice of a drug? Aliment Pharmacol Ther 1994; 8 (suppl 1): 25-32.
12. Steinijans VW. Huber R Hartmann M, Zech K, Bliesath H, Wurst W et al. Lack of pantoprazole drug interactions in man. Int J Clin Pharmacol Ther 1994; 32: 385-99.
13. Bader JP, Delchier JC. Clinical efficacy of pantoprazole compared with ranitidine. Aliment Pharmacol Ther 1994; 8 (suppl 1): 47-52.
14. Belaiche J, Colin R Corinaldesi R Geldof H, Maier C. Efficacy of pantoprazole compared to omeprazole in reflux esophagitis - European rnulticenter study [abstract]. WCG Los Angeles, 21. oktober 1994.
15. Barradell LB, Faulds D, McTavish D. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders. Drugs 1992; 44: 225-50.
16. Müller P. Simon B, Khalil H. Lühmann R Leucht U, Schneider A Dose-range finding study with the proton pump inhibitor pantoprazole in acute duodenal ulcer patients. Z Gastroenterol 1992; 30: 771-5.
17. Schepp W, Rehner M, Witzel L A review of treatment of duodenal and gastric ulcers - pantoprazole vs. omeprazole. Aliment Pharmacol Ther 1994; 8 (suppl 1): 53-7.
18. Judmaier G. Koelz HR Comparison of pantoprazole and ranitidine in the treatment of acute duodenal ulcer. Aliment Pharmacol Ther 1994: 8:81-6.
19. Adamek RJ, Szymanski C, Pfaffenbach B, Opferkuch W, Ricken D, Wegener M. Modified short-term triple therapy with pantoprazole, clarithromycin, and metronidazole for cure of Helicobacter pylori infection. Dtsch Med Wochenschr 1995; 120: 35-60.
20. Brunner G. Harke U. Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. Aliment Pharmacol Ther 1994; 8 (suppl 1): 59-64.